Noninvasive hemoglobin monitoring is an emerging field in clinical medicine that aims to provide accurate assessments of hemoglobin levels without the need for blood draws. This approach is ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Transfusions of red blood cells (RBCs) can be life-saving treatments for patients suffering from anemia, where the body lacks enough healthy RBCs to effectively deliver oxygen around the body. But the ...

monitor, and treat diabetes. A1c, also known as the hemoglobin A1c or HbA1c test, measures the amount of sugar that attaches ...

The researchers found that 14 days of data from the virtual continuous glucose monitors had a similar ability to predict diabetes complications as hemoglobin A1c readings. In addition to the time ...

the oral glucose tolerance test is not the standard test to monitor response to therapy or lifestyle change—this effect is usually assessed by measuring the percentage of hemoglobin in the ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

The researchers found that 14 days of data from the virtual continuous glucose monitors had a similar ability to predict diabetes complications as hemoglobin A1c readings. In addition to the time ...